Background Patients' perceptions are vital to the delivery and evaluation of substance use
treatment. They are most frequently collected at one time-point and measured using patient …

Background Injectable opioid agonist treatment (iOAT) was designed as a pragmatic and
compassionate approach for people who have not benefitted from medication assisted …

Background Across different types of oral Opioid Agonist Treatment for people with Opioid
Use Disorder, receiving a dose that meets their needs is associated with better outcomes …

Background Substitution with opioid-agonists (eg, methadone) has shown to be an effective
treatment for chronic long-term opioid dependency. Patient satisfaction with treatment has …

Methods We conducted 34 semi-structured interviews with individuals currently in or eligible
for iOAT in two German outpatient iOAT clinics. Transcripts were analysed following …

Background Injectable opioid agonist treatment (iOAT) is effective for opioid use disorder
(OUD), yet little is known about client preferences for accessing iOAT (eg, with …

Purpose Injectable opioid agonist treatment (iOAT) is an effective treatment for opioid use
disorder (OUD). To our knowledge, no research has systematically studied client …

Background Satisfaction with services represents a key component of the user's perspective,
and user satisfaction surveys are the most commonly used approach to evaluate the …

Background Addressing inadequacies in the implementation of existing evidence-based
approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative …

Background: Many payers, including Medicaid, the largest payer of opioid use disorder
(OUD) treatment, are pursuing treatment-related quality improvement initiatives. Yet, how …